| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Ann Thorac Surg 2003;76:50-57
© 2003 The Society of Thoracic Surgeons
a department of Cardiology, University Hospital, Lund, Sweden,
b department of Cardiothoracic Surgery, University Hospital, Lund, Sweden
c Clinical Experimental Research Laboratory, Department of Medicine, Sahlgrenska University Hospital/Östra, Göteborg University, Göteborg, Sweden
Accepted for publication December 22, 2002.
* Address reprint requests to Dr Erlinge, Department of Cardiology, Lund University Hospital, S-221 85 Lund, Sweden.
BACKGROUND: The present study was designed to evaluate the relative contribution of different contractile P2 receptors in human saphenous vein compared with internal mammary artery obtained during coronary artery surgery.
METHODS: The isometric tension in endothelium-denuded isolated vessel segments was recorded in vitro. The P2 receptor mRNA expression was quantified by real-time polymerase chain reaction.
RESULTS: The P2X1 receptor agonist, 
ß-MeATP (ß-methylene-adenosine triphosphate), was the most potent vasoconstrictor, with more efficacious contractions in the saphenous vein than in the internal mammary artery. The selective P2Y6 receptor agonist, UDPßS (uridine 5’-O-thiodiphosphate), stimulated more potent contractions in saphenous vein compared with internal mammary artery. Furthermore, UDPßS induced long-lasting contractions for more than 2 hours, explained by the low desensitization rate of the P2Y6 receptor. The ATP-induced vasoconstriction could not be abolished by desensitization of P2X1 receptors with ß-MeATP, or P2Y2/4 receptors with UTP
S (uridine 5’-O-3-thiotriphosphate), indicating the presence of yet another contractile ATP receptor. Based on quantification with real-time polymerase chain reaction, the P2Y11 receptor could be responsible for this ATP contraction.
CONCLUSIONS: The P2X1 and P2Y6 receptors elicit more prominent contractions in the saphenous vein as compared with the internal mammary artery. These results may present one explanation for the differences in the two conduits. It is possible that selective antagonists of P2X1 and P2Y6 receptors could be used to prevent vasospasm and restenosis in the saphenous vein during and after revascularization surgery.
This article has been cited by other articles:
|
|
 |
|
  M. S Amer, J. Li, D. J. O'Regan, D. S. Steele, K. E. Porter, A. Sivaprasadarao, and D. J. Beech Translocon closure to Ca2+ leak in proliferating vascular smooth muscle cells Am J Physiol Heart Circ Physiol, April 1, 2009; 296(4): H910 - H916. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A.-K. Wihlborg, J. Balogh, L. Wang, C. Borna, Y. Dou, B. V. Joshi, E. Lazarowski, K. A. Jacobson, A. Arner, and D. Erlinge Positive Inotropic Effects by Uridine Triphosphate (UTP) and Uridine Diphosphate (UDP) via P2Y2 and P2Y6 Receptors on Cardiomyocytes and Release of UTP in Man During Myocardial Infarction Circ. Res., April 14, 2006; 98(7): 970 - 976. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Burnstock Pathophysiology and therapeutic potential of purinergic signaling. Pharmacol. Rev., March 1, 2006; 58(1): 58 - 86. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A.-K. Wihlborg, L. Wang, O. O. Braun, A. Eyjolfsson, R. Gustafsson, T. Gudbjartsson, and D. Erlinge ADP Receptor P2Y12 Is Expressed in Vascular Smooth Muscle Cells and Stimulates Contraction in Human Blood Vessels Arterioscler Thromb Vasc Biol, October 1, 2004; 24(10): 1810 - 1815. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |
